October 4, 2022
PAR-22-250 - Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional)
National Institute of General Medical Sciences (NIGMS)
The purpose of this Notice is to alert potential applicants of a correction to the "Eligible Organizations" section of PAR-22-250, "Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional)".
Part 2. Section III.1. Eligible Applicants
Previously Read:
Eligible Organizations
Higher Education Institutions
The following types of Higher Education Institutions are always encouraged to apply for NIH support as Public or Private Institutions of Higher Education:
Modified to Read (changes in italics):
Eligible Organizations
Higher Education Institutions
The following types of Higher Education Institutions are always encouraged to apply for NIH support as Public or Private Institutions of Higher Education:
Nonprofits Other Than Institutions of Higher Education
All other aspects of this Funding Opportunity Announcement remain the same.
Michele McGuirl, Ph.D.
National Institute of General Medical Sciences (NIGMS)
Email: [email protected]